Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Henegan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|December 13, 2017
Promising immunotherapy for prostate cancerJohn C Henegan, Guru Sonpavde
Current Opinion in Pediatrics|May 26, 2011
Direct-to-consumer genetic testingJohn C Henegan, Nathaniel H Robin
International Journal of Surgical Pathology|February 24, 2026
<i>BRCA2</i> and <i>NF2</i>-Mutated High-Grade Renal Cell Carcinoma: A Case Report and Literature ReviewMuna M Talafha, John A Ligon, John C Henegan, et al.
Abdominal Radiology (New York)|May 20, 2016
Metastatic renal cell carcinoma imaging evaluation in the era of anti-angiogenic therapiesReza Sirous, John C Henegan, Xu Zhang, et al.
Urologic Oncology|May 7, 2017
Enriching gene expression profiles will help personalize prostate cancer management for African-Americans: A perspectiveSrinivasan Vijayakumar, John C Henegan, Xu Zhang, et al.
Southern Medical Journal|November 3, 2021
Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate CancerAmy B Farkas, Edward D Green, Anson L Thaggard, et al.
Prostate Cancer and Prostatic Diseases|June 20, 2025
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variantMayuko Kanayama, Emeline Colomba, Yusra Shao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2024
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate CancerNaiyu Chen, Colleen B McGrath, Caroline I Ericsson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|December 13, 2017
Promising immunotherapy for prostate cancerJohn C Henegan, Guru Sonpavde
Current Opinion in Pediatrics|May 26, 2011
Direct-to-consumer genetic testingJohn C Henegan, Nathaniel H Robin
International Journal of Surgical Pathology|February 24, 2026
<i>BRCA2</i> and <i>NF2</i>-Mutated High-Grade Renal Cell Carcinoma: A Case Report and Literature ReviewMuna M Talafha, John A Ligon, John C Henegan, et al.
Abdominal Radiology (New York)|May 20, 2016
Metastatic renal cell carcinoma imaging evaluation in the era of anti-angiogenic therapiesReza Sirous, John C Henegan, Xu Zhang, et al.
Urologic Oncology|May 7, 2017
Enriching gene expression profiles will help personalize prostate cancer management for African-Americans: A perspectiveSrinivasan Vijayakumar, John C Henegan, Xu Zhang, et al.
Southern Medical Journal|November 3, 2021
Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate CancerAmy B Farkas, Edward D Green, Anson L Thaggard, et al.
Prostate Cancer and Prostatic Diseases|June 20, 2025
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variantMayuko Kanayama, Emeline Colomba, Yusra Shao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2024
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate CancerNaiyu Chen, Colleen B McGrath, Caroline I Ericsson, et al.
Pageof 1